BTK Inhibitor Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data

Keep up to date with the latest developments in BTK inhibitor&ndash based therapy with this series of 3 expert commentaries focused on emerging clinical trial data toxicity management and patient adherence. Download the slideset based on the commentaries to use in your own presentations to colleagues and patients.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by an educational grant from

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics AbbVie